ArticleClinical and translational radiation oncology2025

PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer.

Anna-Lena Zang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.